SH

Samuel Hou

IS Ichnos Sciences Sa.: 7 patents #1 of 28Top 4%
GS Glenmark Pharmaceuticals S.A.: 3 patents #35 of 189Top 20%
SA Sanofi: 2 patents #699 of 1,881Top 40%
Overall (All Time): #396,235 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12281169 Antibodies that bind to OX40 and their uses Antoine Attinger, Stanislas Blein, Jonathan Back, Rami Lissilaa 2025-04-22
12006367 CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production Romain Ollier, Rami Lissilaa, Darko Skegro, Jonathan Back 2024-06-11
11891454 Production of T cell retargeting hetero-dimeric immunoglobulins Stanislas Blein, Romain Ollier, Darko Skegro 2024-02-06
11851502 Production of T cell retargeting hetero-dimeric immunoglobulins Stanislas Blein, Romain Ollier, Darko Skegro 2023-12-26
11773166 CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production Romain Ollier, Rami Lissilaa, Darko Skegro, Jonathan Back 2023-10-03
11407839 Antibodies that bind to OX40 and their uses Antoine Attinger, Stanislas Blein, Jonathan Back, Rami Lissilaa 2022-08-09
11267891 Fc variant antibodies and their uses Stanislas Blein, Darko Skegro 2022-03-08
10640564 Antibodies that bind to CCR6 and their uses Rami Lissilaa, Adrian Walmsley, Stanislas Blein, Romain Ollier, Jeremy Loyau 2020-05-05
9493563 Production of T cell retargeting hetero-dimeric immunoglobulins Stanislas Blein, Romain Ollier, Darko Skegro 2016-11-15
8975376 Anti-alpha2 integrin antibodies and their uses Stanislas Blein, Darko Skegro 2015-03-10
8748585 Antibodies that bind to OX40 and their uses Antoine Attinger, Stanislas Blein, Jonathan Back, Rami Lissilaa 2014-06-10
8236315 Humanized antibodies specific for von Willebrand factor Elias Lazarides, Catherine Woods, Xiaomin Fan, Harald Mottl, Stanislas Blein +1 more 2012-08-07